Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ausdal Financial Partners Inc. lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,996 shares of the biopharmaceutical company’s stock after purchasing an additional […]
Mutual of America Capital Management LLC reduced its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 188,903 shares of the biopharmaceutical company’s stock after selling 5,566 shares during […]
Mutual of America Capital Management LLC reduced its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.9% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 188,903 shares of the biopharmaceutical company’s stock after selling 5,566 shares during the quarter. Mutual of America […]
Gilead Sciences (NASDAQ:GILD – Free Report) had its target price lowered by Wells Fargo & Company from $90.00 to $84.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has an equal weight rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued research reports about […]
Gilead Sciences (NASDAQ:GILD – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $6.85-7.25 for the period, compared to the consensus estimate of $7.23. Gilead Sciences also updated its FY 2024 guidance to 6.850-7.250 EPS. Gilead Sciences Stock Performance Shares of […]